Deciphering the Intratumoral Histologic Heterogeneity of Lung Adenocarcinoma Using Radiomics

Overview

Journal Eur Radiol

Specialty Radiology

Date 2025 Feb 12

PMID 39939422

Authors

Jae Mo Koo

Jonghoon Kim

Junghee Lee

Soohyun Hwang

Hyo Sup Shim

Tae Hee Hong

Yu Jin Oh

Hong Kwan Kim

Chang Young Lee

Byung Jo Park

Ho Yun Lee

Affiliations

Soon will be listed here.

Abstract

Objective: To discern highly aggressive intratumoral areas among lung adenocarcinoma (LUAD) and its impact on occult nodal metastases and the recurrence rate with radiomic analysis.

Methods: This prospective dual-institution study analyzed clinical information and high-resolution preoperative CT of 528 patients from institution A and 249 patients from institution B. We extracted radiomic features and performed pathologic evaluations for resected tumors, based on the 2020 International Association for the Study of Lung Cancer (IASLC) classification. Prediction models were developed to discern micropapillary and solid patterns within LUAD using clinical and radiomic features from institution A through logistic analysis.

Results: Six selected CT radiomic features, sex, CTR (consolidation-to-tumor ratio), and solid diameter were selected to develop the prediction models. A composite model of radiomic and clinical characteristics outperformed radiomics-only and clinical-only models (AUC, 95% CI; the composite model: 0.84 [0.81-0.87]; the radiomics model: 0.82 [0.78-0.87]; the clinical model: 0.80 [0.76-0.83]) in institution A. External validation was performed with institution B cohort, showing even better results (AUC, 95% CI; the composite model: 0.91 [0.87-0.94]; the radiomics model: 0.89 [0.84-0.94]; the clinical model: 0.88 [0.84-0.92]).

Conclusions: Our study underscores the potential of radiomics to preoperatively predict aggressive histologic patterns in LUAD, enabling precise treatment planning and prognosis estimation.

Key Points: Question Can any adjuvant methods address the limitations of core needle biopsies, which are invasive and may not capture the full heterogeneity of lung adenocarcinoma? Findings In a prospective study of 528 patients with cT1N0M0 lung adenocarcinoma, a composite model of clinical characteristics, conventional CT findings, and radiomics features predicted high-grade cancers. Clinical relevance Preoperative non-invasive diagnosis of histologically high-grade tumors using radiomics analysis offers crucial information for the treatment of lung adenocarcinoma with respect to occult lymph node metastasis and recurrence rate.

References

Lee G, Park H, Bak S, Lee H . Radiomics in Lung Cancer from Basic to Advanced: Current Status and Future Directions. Korean J Radiol. 2020; 21(2):159-171. PMC: 6992443. DOI: 10.3348/kjr.2019.0630. View

Travis W, Brambilla E, Nicholson A, Yatabe Y, Austin J, Beasley M . The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol. 2015; 10(9):1243-1260. DOI: 10.1097/JTO.0000000000000630. View

Moreira A, Ocampo P, Xia Y, Zhong H, Russell P, Minami Y . A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee. J Thorac Oncol. 2020; 15(10):1599-1610. PMC: 8362286. DOI: 10.1016/j.jtho.2020.06.001. View

Cha M, Lee H, Lee K, Jeong J, Han J, Shim Y . Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome. J Thorac Cardiovasc Surg. 2013; 147(3):921-928.e2. DOI: 10.1016/j.jtcvs.2013.09.045. View

Tsao M, Marguet S, Le Teuff G, Lantuejoul S, Shepherd F, Seymour L . Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection. J Clin Oncol. 2015; 33(30):3439-46. PMC: 4606061. DOI: 10.1200/JCO.2014.58.8335. View

Lee G, Lee H, Jeong J, Han J, Cha M, Lee K . Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes. Am J Surg Pathol. 2015; 39(5):660-6. DOI: 10.1097/PAS.0000000000000399. View

Lee G, Park H, Lee H, Ahn J, Sohn I, Lee S . Tumor Margin Contains Prognostic Information: Radiomic Margin Characteristics Analysis in Lung Adenocarcinoma Patients. Cancers (Basel). 2021; 13(7). PMC: 8037340. DOI: 10.3390/cancers13071676. View

Wang Y, Zheng D, Luo J, Zhang J, Pompili C, Ujiie H . Risk stratification model for patients with stage I invasive lung adenocarcinoma based on clinical and pathological predictors. Transl Lung Cancer Res. 2021; 10(5):2205-2217. PMC: 8182714. DOI: 10.21037/tlcr-21-393. View

Yotsukura M, Asamura H, Motoi N, Kashima J, Yoshida Y, Nakagawa K . Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung. J Thorac Oncol. 2021; 16(8):1312-1320. DOI: 10.1016/j.jtho.2021.04.007. View

10.

Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K . Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022; 399(10335):1607-1617. DOI: 10.1016/S0140-6736(21)02333-3. View

11.

Suzuki K, Watanabe S, Wakabayashi M, Saji H, Aokage K, Moriya Y . A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg. 2021; 163(1):289-301.e2. DOI: 10.1016/j.jtcvs.2020.09.146. View

12.

Altorki N, Wang X, Kozono D, Watt C, Landrenau R, Wigle D . Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer. N Engl J Med. 2023; 388(6):489-498. PMC: 10036605. DOI: 10.1056/NEJMoa2212083. View

13.

Nitadori J, Bograd A, Kadota K, Sima C, Rizk N, Morales E . Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. J Natl Cancer Inst. 2013; 105(16):1212-20. PMC: 3748005. DOI: 10.1093/jnci/djt166. View

14.

Bains S, Eguchi T, Warth A, Yeh Y, Nitadori J, Woo K . Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis. J Thorac Oncol. 2018; 14(1):72-86. PMC: 6309652. DOI: 10.1016/j.jtho.2018.09.008. View

15.

Wang C, Yang J, Lu M . Micropapillary Predominant Lung Adenocarcinoma in Stage IA Benefits from Adjuvant Chemotherapy. Ann Surg Oncol. 2019; 27(6):2051-2060. DOI: 10.1245/s10434-019-08113-0. View

16.

Zhang J, Wu J, Tan Q, Zhu L, Gao W . Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification. J Thorac Oncol. 2013; 8(9):1196-202. DOI: 10.1097/JTO.0b013e31829f09a7. View

17.

Song S, Park H, Lee G, Lee H, Sohn I, Kim H . Imaging Phenotyping Using Radiomics to Predict Micropapillary Pattern within Lung Adenocarcinoma. J Thorac Oncol. 2016; 12(4):624-632. DOI: 10.1016/j.jtho.2016.11.2230. View

18.

Huang K, Ko P, Yao C, Hsu C, Fang H, Tu C . Inaccuracy of lung adenocarcinoma subtyping using preoperative biopsy specimens. J Thorac Cardiovasc Surg. 2017; 154(1):332-339.e1. DOI: 10.1016/j.jtcvs.2017.02.059. View

19.

Aerts H, Velazquez E, Leijenaar R, Parmar C, Grossmann P, Carvalho S . Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014; 5:4006. PMC: 4059926. DOI: 10.1038/ncomms5006. View

20.

Choi Y, Kim J, Park H, Kim H, Kim J, Jeong J . Rethinking a Non-Predominant Pattern in Invasive Lung Adenocarcinoma: Prognostic Dissection Focusing on a High-Grade Pattern. Cancers (Basel). 2021; 13(11). PMC: 8200026. DOI: 10.3390/cancers13112785. View